Condition
Muscular Dystrophies clinical trials and research
As of November 12, 2026, Find a Trial lists 11 Muscular Dystrophies clinical trials that are recruiting, at sites in 11 countries (most in United States (6), Italy (4), Spain (2)). By phase: Phase 3 (2). There are also 11 NIH-funded research projects on Muscular Dystrophies, with $5.8 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 11Clinical trials
- 11NIH research projects
- 11Countries
Newest Muscular Dystrophies clinical trials
All recruiting trials (11)
-
Zeleciment Rostudirsen (DYNE-251) for Duchenne Muscular Dystrophy in Ambulatory Boys
This trial tests whether intravenous Zeleciment Rostudirsen (DYNE-251) given every 4 weeks is safe and helps improve function in ambulatory boys with Duchenne muscular dystrophy who have a specific dystrophin gene mutation.
-
AOC 1044 in Duchenne Muscular Dystrophy with Exon 44 Skipping
This study tests whether intravenous AOC 1044 helps boys with Duchenne muscular dystrophy caused by mutations amenable to exon 44 skipping.
-
Virtual Park for Children: Dual-Task Training with Virtual Reality
This study tests whether a virtual reality, dual-task cycling program can slow motor decline and boost engagement for kids with neuromuscular diseases compared with standard therapy.
-
Implanted brain interface to let people with severe paralysis control assistive devices
It will try an implanted brain interface that records and stimulates brain signals so adults with severe paralysis can control assistive devices and receive sensory feedback.
-
Measuring muscle health with a handheld electrical impedance device (mScan)
This project will test whether a handheld mScan device can quickly measure muscle health in adults with myopathies and in people without muscle disease by comparing its readings to MRI.
-
Reducing fear of falling in people with muscular dystrophy
This study tests whether adding cognitive-behavioral therapy to motor rehabilitation helps people aged 16–65 with muscular dystrophy who have a persistent fear of falling.
-
Natural history study of LAMA2 muscular dystrophy in children
This study is trying to understand how LAMA2 muscular dystrophy affects children over time to help improve future treatments.
-
Observing walking patterns in patients with neuromuscular diseases
This study is testing how walking patterns change in people with neuromuscular diseases and whether wearable sensors can help track their daily activity and fatigue levels.
-
Using a brain-computer interface to help people with speech difficulties communicate
This study is testing a brain-computer interface to help people who can't speak due to conditions like ALS communicate by turning their thoughts into speech.
-
Using a neural interface to help people with tetraplegia control devices with their thoughts
This study is testing a new brain interface that helps people with tetraplegia, especially those with ALS, control devices like computers just by thinking about it.
-
Using brain signals to control devices for movement and speech
This study is testing if people with severe neurological disorders can use brain signals to control devices that help them move and speak better.
NIH-funded research (11)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Noninvasive breathing imaging to guide care for people with muscular dystrophy
A noninvasive imaging tool called electrical impedance tomography (EIT) will be studied to help decide when to start noninvasive ventilation for people with muscular dystrophy.
-
Bicistronic gene therapy for limb girdle muscular dystrophy type R9
A patient-facing overview of a first-in-class gene therapy approach using two genes delivered by AAV to help people with LGMDR9.
-
Understanding why scarring happens in muscular dystrophy muscles
Researchers are studying why scar tissue forms in muscles affected by muscular dystrophy and how to slow or reverse it in patients.
-
Addressing Shortcomings of AAV Gene Therapies for Muscular Dystrophy
A national research center is working to improve AAV-based gene therapies for Duchenne and related muscular dystrophies so that patients may get safer, more effective treatments.
-
Two-gene AAV therapy for Limb-Girdle Muscular Dystrophy R9
Developing a two-gene AAV gene therapy to replace the faulty gene and rebuild muscle for people with LGMDR9 (Limb Girdle Muscular Dystrophy Type R9).
-
Improving Gene Therapies for Muscular Dystrophies
This center is working to improve gene therapies for Duchenne and Limb Girdle Muscular Dystrophy, aiming to make them safer and more effective for patients.
-
Stopping Muscle Scarring in Muscular Dystrophies
This project explores how muscle scarring, called fibrosis, develops in muscular dystrophies like Duchenne MD, hoping to find new ways to help muscles heal better.
-
Understanding Muscle Weakness in Muscular Dystrophies
This research explores how certain proteins called actins help maintain muscle structure and function in people with muscular dystrophy.
-
Understanding how caspases affect muscle development and disorders
This study is looking at how certain enzymes, called caspases, affect muscle growth and breakdown, especially in people with muscular dystrophies, to better understand how they might help or hurt muscle development.
-
Gene therapy for Limb Girdle Muscular Dystrophy Type R9
This study is testing a new gene therapy for people with Limb Girdle Muscular Dystrophy Type R9 that aims to replace the faulty gene and help rebuild muscle strength, with hopes of improving muscle function and slowing down the disease.
-
Creating improved gene therapy vectors for muscular dystrophies
This study is working on improving a type of virus used in gene therapy to help treat Duchenne muscular dystrophy (DMD) by making it safer and more effective, so that patients can benefit from better treatments with fewer side effects.
Related topics
Quick answers
How many Muscular Dystrophies clinical trials are recruiting right now?
11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in United States (6 trials), Italy (4 trials), Spain (2 trials), Australia (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.